Article
Correlate tumor mutation burden with immune signatures in human cancers
11 Jan 2019
Abstract excerpt
BACKGROUND: Tumor mutation burden (TMB) has been associated with cancer immunotherapeutic response and cancer prognosis. Although many explorations have revealed that high TMB may yield many neoantigens to incite antitumor immune response, a systematic exploration of the correlation between TMB and immune signatures in different cancer types is lacking. RESULTS: We classified cancer into the lower-TMB subtype and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
